March 24, 2023
SymBio Pharmaceuticals Limited
Fuminori Yoshida
Representative Director
President and Chief Executive Officer(Securities Code: 4582)

Notice of Shareholder Voting Results for the18th Annual General Meeting of Shareholders
SymBio Pharmaceuticals Limited (“the Company”) today announced the shareholder voting results forthe 18th Annual General Meeting of Shareholders held on March 23rd, 2023 (the “ShareholdersMeeting”) as below. All resolutions were approved as proposed by advance voting (by postal mail or theinternet) and the votes exercised in person at the Shareholders Meeting.
1. Resolutions
Proposal 1: Partial amendment to the Articles of Incorporation
The Articles of Incorporation will be partially amended to increase the total number of authorizedshares. The purpose of the increase is to enable the Company to implement a flexible and agile capital
policy in the future.
Proposal 2: Election of four (4) Directors (excluding Directors serving as Audit & Supervisory
Committee Members)
Election of Fuminori Yoshida, Shigetoshi Matsumoto, Bruce David Cheson, and Eiji Ebinuma as
Directors of the Company.
Proposal 3: Election of one (1) Director serving as Substitute Audit & Supervisory Committee Member
Election of Takashi Watanabe as Substitute Audit & Supervisory Committee Member.
2. Number of votes indicating approval, disapproval, abstention, or counted as invalid, andrequirements for the proposed resolutions to be approved and the voting outcome
Total number of eligible votes: 391,102
Total number of votes exercised (including votes exercised at the Shareholders Meeting): 204,823

Resolutions

Approval Disapprova Invalid
Require(number of l (number (numbermentvotes)of votes) of votes)

Votingoutcome(%)

Proposal 1
Partial amendments to the Articles ofIncorporation

172,728

Proposal 2

129,157

1,111

(*)

Approved（84.33）Election of Four (4)Directors(excluding
Directors serving as
Audit & Supervisory
CommitteeMembers)

Fuminori Yoshida

189,929

12,342

727

Shigetoshi Matsumoto

192,379

9,892

727

Bruce David Cheson

192,347

9,924

727

Eiji Ebinuma

191,999

10,272727(*)

Approved（92.73）
Approved（93.92）
Approved（93.91）
Approved（93.74）

Proposal 3
Election of one (1)Director serving as
Approved
Substitute Audit &Takashi Watanabe
193,360
8,919
713
(*)
（94.40）Supervisory
Committee Member*For Proposal 1, more than or equal to one-third of shareholders who are eligible to vote need
to be present at the Shareholders Meeting, and more than or equal to two-thirds of the votes
must be in favor to approve the resolution.
For Proposals 2 to 3, more than or equal to one-third of shareholders who are eligible to voteneed to be present at the Shareholders Meeting, and more than fifty percent (50%) of the votes
must be in favor to approve the resolutions.

3. Reason for a portion of the votes exercised at the Shareholders Meeting not reflected in total votes
As the proposed resolutions were approved based on the total of confirmed advance votes and votes
exercised in person at the Shareholders Meeting, certain votes for or against, or abstentions, are
not reflected in the above total number of votes exercised.
[Contact]
Investor Relations
Tel: +81(0)3 5472 11252